The value of pharmaceutical expertise in the detection and management of drug interactions with targeted therapies in melanoma.
Resource Type
Editorial & Opinion
Authors
Demarez B; Dermatology and Skin Cancer Unit, CHU Timone, Aix-Marseille Université (AMU), Assistance Publique Hôpitaux de Marseille (APHM), Marseille, France. Electronic address: berangere-d@live.fr.; Gaudy C; Dermatology and Skin Cancer Unit, CHU Timone, Aix-Marseille Université (AMU), Assistance Publique Hôpitaux de Marseille (APHM), Marseille, France.; Amatore F; Dermatology and Skin Cancer Unit, CHU Timone, Aix-Marseille Université (AMU), Assistance Publique Hôpitaux de Marseille (APHM), Marseille, France.; Correard F; Pharmacy, CHU Timone, Aix-Marseille Université, INSERM, MMG, Assistance Publique Hôpitaux de Marseille (APHM), Marseille, France.; Tabèle C; Pharmacy, CHU Timone, Aix-Marseille Université, INSERM, MMG, Assistance Publique Hôpitaux de Marseille (APHM), Marseille, France.; Richard MA; Centre for Study and Research on Health Services and Quality of Life (CEReSS-EA 3279), Aix-Marseille Université (AMU), Dermatology and Skin Cancer Unit, CHU Timone, Assistance Publique Hôpitaux de Marseille (APHM), Marseille, France.
Source
Publisher: Masson Country of Publication: France NLM ID: 7702013 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0151-9638 (Print) Linking ISSN: 01519638 NLM ISO Abbreviation: Ann Dermatol Venereol Subsets: PubMed not MEDLINE; MEDLINE